StockData
Shattuck Labs, Inc. logo

Shattuck Labs, Inc. (STTK) stock

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$4.47−0.12 (-2.61%)

Close on Nov 18, 2026Market cap $448.62MP/E –Yield –

Shattuck Labs free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Shattuck Labs's free cash flow for the twelve months ending Dec 31, 2025 was -$39.95M. For fiscal 2025 it was -$39.95M. The highest annual figure on record is -$21.45M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$39.95M–
FY2024Dec 31, 2024-$60.57M–
FY2023Dec 31, 2023-$81.64M–
FY2022Dec 31, 2022-$106.11M–
FY2021Dec 31, 2021-$65.04M–
FY2020Dec 31, 2020-$34.39M–
FY2019Dec 31, 2019-$21.45M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$8.49M–
Q3 FY2025Sep 30, 2025-$9.00M–
Q4 FY2024Dec 31, 2024-$17.37M–
Q3 FY2024Sep 30, 2024-$16.11M–
Q2 FY2024Jun 30, 2024-$10.94M–
Q1 FY2024Mar 31, 2024-$16.16M–
Q4 FY2023Dec 31, 2023-$19.44M–
Q3 FY2023Sep 30, 2023-$16.75M–
Q2 FY2023Jun 30, 2023-$18.91M–
Q1 FY2023Mar 31, 2023-$26.54M–
Q4 FY2022Dec 31, 2022-$24.53M–
Q3 FY2022Sep 30, 2022-$28.81M–
Q2 FY2022Jun 30, 2022-$24.00M–
Q1 FY2022Mar 31, 2022-$28.77M–
Q4 FY2021Dec 31, 2021-$20.71M–
Q3 FY2021Sep 30, 2021-$13.96M–
Q2 FY2021Jun 30, 2021-$16.67M-993.5%
Q1 FY2021Mar 31, 2021-$13.71M–
Q4 FY2020Dec 31, 2020-$14.24M–
Q3 FY2020Sep 30, 2020-$11.45M–
Q2 FY2020Jun 30, 2020$1.87M–
Q1 FY2020Mar 31, 2020-$10.56M–
Q4 FY2019Dec 31, 2019-$7.65M–

More Shattuck Labs figures

See a number that looks wrong?